Radmila Janković - Concepedia

Author

Radmila Janković

Also Known As

Janković, Radmila, R Jankovic, R Janković, R. JANKOVIC, R. Jankovic, R. Janković, Radmila Jankovic, Radmila Janković, Radmila M Jankovic, Radmila M Janković

117

Publications

578

Citations

H-Index

Concepts

All Affiliations

Oncology Institute of Vojvodina University of Belgrade Institute of Public Health of Serbia University Children's Hospital, Belgrade Military Medical Academy

About

Radmila Janković is an author at Oncology Institute of Vojvodina specializing in medicine, pathology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	229
2	Public Health	3	3	64
3	Cell Biology	3	3	92
4	Natural Sciences	1	1	55
5	Biochemistry	1	1	55

Radmila Janković

Publications

385

Citations

H-Index

Page 1

	Year	Citations
Comparative in vivo evaluation of novel formulations based on alginate and silver nanoparticles for wound treatments Jasmina Stojkovska, Zeljka Djurdjevic, Ivan Jančić, Journal of Biomaterials Applications	2018	58
Cytotoxic activity of ethanol extracts of in vitro grown Cistus creticus subsp. creticus L. on human cancer cell lines Marijana Škorić, Slađana Todorović, Nevenka Gligorijević, Industrial Crops and Products Ethanol ExtractsMedicineToxicologyCytotoxic ActivityPharmacology	2012	55
Picolinate ruthenium(II)–arene complex with in vitro antiproliferative and antimetastatic properties: Comparison to a series of ruthenium(II)–arene complexes with similar structure Nevenka Gligorijević, Sandra Aranđelović, Lana Filipović, Journal of Inorganic Biochemistry Inorganic ChemistryMedicinal ChemistrySimilar StructureBiochemistryNatural Sciences	2011	55
Cytotoxic activity of Nepeta rtanjensis Diklić & Milojević essential oil and its mode of action Marijana Škorić, Nevenka Gligorijević, Milena Čavić, Industrial Crops and Products Milojević Essential OilMedicineHerbal MedicinePathologyPhytopharmacology	2017	39
Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C. Siniša Radulović, Mirjana Branković-Magić, Emina Mališić, PubMed ImmunologyImmunotherapyCancer-associated VirusCervical Cancer PreventionHuman Papillomavirus Vaccines	2009	27
Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process Tushar B. Deb, Annie Zuo, Robert J. Barndt, Breast Cancer Research and Treatment Trastuzumab ResistanceParadoxical Pten-mediated ProcessBreast OncologyPnck OverexpressionMedicine	2015	24
Detection and genotyping of human papillomaviruses and their role in the development of ovarian carcinomas Emina Mališić, Radmila Janković, Ksenija Jakovljevic Archives of Gynecology and Obstetrics Tumor BiologyCancer DetectionHuman Papillomavirus VaccinesOvarian CarcinomasMedicine	2012	24
Progesterone receptor status of breast cancer metastases Mirjana Branković-Magić, Radmila Janković, Z. Nešković-Konstantinović, Journal of Cancer Research and Clinical Oncology Breast OncologyHormonal ReceptorGynecologyBreast CancerProgesterone Receptor Status	2001	23
Prognostic relevance of autophagy-related markers p62, LC3, and Beclin1 in ovarian cancer Ljubiša Jovanović, Aleksandra Nikolić, Sandra Dragičević, Croatian Medical Journal	2022	19
siRNA and miRNA for the treatment of cancer. Radmila Janković, Siniša Radulović, Mirjana Branković-Magić PubMed Radiation OncologySpecific Cancer TreatmentRna InterferenceMedicinePathology	2009	13

Page 1